FMP

FMP

Enter

AUROPHARMA.NS - Aurobindo Pharma Lim...

Financial Summary of Aurobindo Pharma Limited(AUROPHARMA.NS), Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharm

photo-url-https://financialmodelingprep.com/image-stock/AUROPHARMA.NS.png

Aurobindo Pharma Limited

AUROPHARMA.NS

NSE

Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In addition, the company develops and manufactures peptides, as well as biocatalysts for use in the pharmaceutical and chemical industries. Further, it is developing biosimilar, inhalers, transdermal patches, vaccines, topicals, and depot injections. The company also exports its products. It serves multinational companies. The company has an agreement with COVAXX to develop and commercialize COVID-19 Vaccine for India and UNICEF. Aurobindo Pharma Limited was incorporated in 1986 and is headquartered in Hyderabad, India.

1103.4 INR

19.35 (1.75%)

About

ceo

Mr. Kambam Nityananda Reddy

sector

Healthcare

industry

Drug Manufacturers - Specialty & Generic

website

https://www.aurobindo.com

exchange

NSE

Description

Aurobindo Pharma Limited engages in the research, development, manufacture, and sale of active pharmaceutical ingredients, generic pharmaceuticals, and related services in India. The company primarily offers oral solids, injectables, and over-the-counter drugs, as well as active pharmaceutical ingredients and finished dosage forms for cardiovascular, central nervous system, gastroenterology, anti-allergies, anti-diabetics, anti-retroviral, antibiotics, dermatology, respiratory, and oncology. It is also involved in the development of a product pipeline in biosimilar and vaccine segments; and custom research and manufacturing activities for the bio-tech and pharmaceutical community. In additio...

CIK

N/A

ISIN

INE406A01037

CUSIP

Y04527142

Address

Galaxy, Plot No. 1

Phone

91 40 6672 5000

Country

IN

Employee

23,451

IPO Date

Jan 15, 1996

Summary

CIK

-

Exchange

NSE

Industry

Drug Manufacturers -...

Sector

Healthcare

CUSIP

Y04527142

ISIN

INE406A01037

Country

IN

Price

1.1k

Beta

0.58

Volume Avg.

2.65M

Market Cap

646.53B

Shares

-

52-Week

581.25-1177.1

DCF

865.63

ROE

-

ROA

-

Operating Margin

-

Debt/Equity

-

P/E

23.35

P/B

-

Website

https://www.aurobindo.com

Historical Prices

We are unable to load the chart at this time.

fmp-logo

Financial Statement

We are unable to load the chart at this time.

fmp-logo

Earnings

We are unable to load the chart at this time.

fmp-logo

Upgrades and Downgrades

We are unable to load this data!

fmp-logo

People Also Watch

page loading card

Latest AUROPHARMA.NS News

It looks like there's no news available.

fmp-logo
FMP

FMP

Financial Modeling Prep API provides real time stock price, company financial statements, major index prices, stock historical data, forex real time rate and cryptocurrencies. Financial Modeling Prep stock price API is in real time, the company reports can be found in quarter or annual format, and goes back 30 years in history.
twitterlinkedinfacebookinstagram
2017-2024 © Financial Modeling Prep